Metabolic syndrome in HIV-positive patients

被引：8
作者：
Drelichowska, Justyna [1 ,2 ]
Kwiatkowska, Wieslawa [1 ,2 ]
Knysz, Brygida [3 ]
Witkiewicz, Wojciech [1 ]
机构：
[1] Reg Specialist Hosp Wroclaw, Wrovasc Integrated Cardiovas Ctr, Res Dev Ctr, Wroclaw, Poland
[2] Reg Specialist Hosp Wroclaw, Res Dev Ctr, Dept Angiol, Wroclaw, Poland
[3] Wroclaw Med Univ, Liver Diseasesand Acquired Immune Deficiencies, Dept Infect Dis, Wroclaw, Poland
来源：
HIV & AIDS REVIEW | 2015年 / 14卷 / 02期
关键词：
HIV; Antiretroviral therapy; Metabolic syndrome; Lipodystrophy; Hypertriglyceridemia; Cholesterol;
D O I：
10.1016/j.hivar.2014.09.002
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
A number of abnormalities related to chronic infection and antiretroviral treatment may be observed in a population of HIV-positive patients. A particular state of coexisting, interacting and interrelated disorders referred to as metabolic syndrome is observed in 7-45% of patients infected with HIV. Its presence is related to the abnormalities of adipose tissue distribution known under a common name of ART-related lipodystrophy syndrome. The most common features of metabolic syndrome observed in a course of HIV infection include hypertriglyceridemia and low HDL cholesterol concentration, while increased waist circumference is the least frequently observed. Treatment of metabolic syndrome encompasses revision and possible changes in antiretroviral therapy, diet, changes in physical activity, pharmacological management of individual components of the syndrome. In this publication we present a review of problems concerning epidemiology, pathophysiology, symptoms and treatment of metabolic syndrome in HIV-positive patients. (C) 2014 Polish AIDS Research Society. Published by Elsevier Sp.zo.o.All rights reserved.
引用
收藏
页码：35 / 41
页数：7
相关论文
共 47 条
[11]   Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].
Carr, A ;
Samaras, K ;
Thorisdottir, A ;
Kaufmann, GR ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1999, 353 (9170) :2093-2099
[12]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[13]   Adverse effects of antiretroviral therapy [J].
Carr, A ;
Cooper, DA .
LANCET, 2000, 356 (9239) :1423-1430
[14]   Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance [J].
Carr, A ;
Samaras, K ;
Chisholm, DJ ;
Cooper, DA .
LANCET, 1998, 351 (9119) :1881-1883
[15]   Metabolic syndrome: A major risk factor for atherosclerosis in HIV-infected patients (SHIVA study) [J].
de Saint Martin, Luc ;
Pasquier, Elisabeth ;
Roudaut, Nathalie ;
Vandhuick, Olivier ;
Vallet, Sophie ;
Bellein, Veronique ;
Bressollette, Luc .
PRESSE MEDICALE, 2008, 37 (04) :579-584
[16]   Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study [J].
De Socio, G. V. L. ;
Martinelli, C. ;
Ricci, E. ;
Orofino, G. ;
Valsecchi, L. ;
Vitiello, P. ;
Martinelli, L. ;
Quirino, T. ;
Maggi, P. ;
Bonfanti, P. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (04) :267-272
[17]   Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy [J].
Estrada, Vicente ;
Martinez-Larrad, Maria Teresa ;
Gonzalez-Sanchez, Jose Luis ;
de Villar, Noemi G. P. ;
Zabena, Carina ;
Fernandez, Cristina ;
Serrano-Rios, Manuel .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (07) :940-945
[18]  
EuropeanAIDSClinicalSociety(EACS), GUID INF AD IN AD EU
[19]   Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients [J].
Freitas, Paula ;
Carvalho, Davide ;
Souto, Selma ;
Santos, Ana Cristina ;
Xerinda, Sandra ;
Marques, Rui ;
Martinez, Esteban ;
Sarmento, Antonio ;
Medina, Jose Luis .
BMC INFECTIOUS DISEASES, 2011, 11
[20]  
Gougeon ML, 2004, ANTIVIR THER, V9, P161
12345